People with familial amyloid polyneuropathy (FAP) have fewer autonomic symptoms caused by damage to the nerves that control involuntary…
Katherine Poinsatte, PhD
Katherine earned their PhD in Neuroscience from the University of Texas Southwestern Medical Center in Dallas, Texas where they studied the role of the immune system in promoting synaptic connectivity during recovery from stroke. They have received international recognition for their research on post-stroke neuroplasticity and neuroinflammation, as well as for developing image analysis pipelines using volumetric imaging methods and a supervised machine learning model.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Katherine Poinsatte, PhD
A single dose of nucresiran, an experimental therapy for familial amyloid polyneuropathy (FAP) and other forms of ATTR amyloidosis, safely…
One year after a single dose of Intellia Therapeutics’ experimental gene-editing therapy NTLA-2001, blood levels of the disease-driving…
The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. has approved the injection therapy eplontersen — under…
People with hereditary transthyretin amyloidosis (hATTR), a group of diseases that includes familial amyloid polyneuropathy (FAP), have significantly shorter…